Gamma-arylated allylamine compounds for novel GPCR activity exploration
A library of novel gamma-arylated allylamine compounds synthesized to explore chemical space around this functional group, with potential applications in GPCR-targeted drug discovery. Available for collaborative research, licensing, or further development partnerships.
Overview
This offering consists of a library of novel gamma-arylated allylamine compounds, including structures with one or two aryl groups at the gamma-position, as well as tri-arylated variants with three aryl groups at the gamma and gamma' positions. The compounds were produced through a chemistry-driven synthesis approach aimed at exploring the chemical space surrounding this functional group. The initial research hypothesis focused on potential activity at G-protein coupled receptors (GPCRs), a major class of drug targets, though biological testing has not yet been conducted. These compounds represent an underexplored structural motif that may offer new opportunities for pharmaceutical and agrochemical discovery.
Technical specifications
Key features:
- A series of gamma-arylated allylamine compounds with controlled aryl substitution patterns
- Variants include mono-arylated (one aryl group at gamma), di-arylated (two aryl groups at gamma), and tri-arylated (three aryl groups at gamma and gamma') structures
- Chemically synthesized through a systematic, chemistry-driven approach
- Designed to explore a unique region of chemical space relevant to GPCR ligand discovery
- GPCR activity remains untested, presenting an opportunity for biological screening and characterization
Potential applications:
- Lead compound identification for GPCR-targeted drug discovery
- Structure-activity relationship studies around the allylamine scaffold
- Starting point for medicinal chemistry optimization programs
- Potential utility in agrochemical or material science research
Technology readiness level
The compounds have been successfully synthesized, confirming the feasibility of the synthetic route. However, biological validation, including GPCR activity screening, has not yet been performed. This represents an early-stage research asset that would benefit from collaborative partnerships to advance testing, characterization, and potential optimization. The technology is well-suited for co-development arrangements, sponsored research collaborations, or licensing to organizations with capabilities in high-throughput screening, medicinal chemistry, and drug discovery.
About University of Toledo
The University of Toledo is a comprehensive public research university serving the Great Lakes region, combining broad academic programs with a major health science campus. Industry collaborates through co‑located labs on the Main and Health Science campuses, an established engineering co‑op program that places students with regional employers, and a research and technology park offering incubator and flexible lab space. Proximity to Detroit and northwest Ohio’s glass and advanced manufacturing base provides convenient access to suppliers, testing resources, and logistics. Faculty secure competitive federal support from agencies such as NSF, NIH, DOE, and DoD. A dedicated technology transfer office, corporate engagement team, and startup services streamline IP, licensing, and sponsored research.
delivered to your inbox.